Growth hormone receptor antagonism improves tumoral chemo-immunotherapy response in a mouse model of lung cancer.

Similarly, in a separate cohort of 86 NSCLC patients, higher CXCL10 expression was associated with a trend toward prolonged overall survival, although this difference did not reach statistical significance (119.5 vs. 95.5 months) ( Fig. 3 E ).

also in 111,027 other papers